| Product Code: ETC9613488 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Artificial Intelligence (AI) in Drug Discovery Market - Industry Life Cycle |
3.4 Taiwan Artificial Intelligence (AI) in Drug Discovery Market - Porter's Five Forces |
3.5 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Offering, 2021 & 2031F |
3.9 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.10 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for innovative drug discovery solutions to combat complex diseases |
4.2.2 Technological advancements in artificial intelligence algorithms and tools |
4.2.3 Rising investments in research and development in the healthcare sector |
4.3 Market Restraints |
4.3.1 High initial investment required for implementing AI technologies in drug discovery |
4.3.2 Data privacy and security concerns related to handling sensitive patient information |
4.3.3 Lack of skilled professionals proficient in both AI and drug discovery domains |
5 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Trends |
6 Taiwan Artificial Intelligence (AI) in Drug Discovery Market, By Types |
6.1 Taiwan Artificial Intelligence (AI) in Drug Discovery Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Novel Drug Candidates, 2021- 2031F |
6.1.4 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Drug Optimization and Repurposing Preclinical Testing and Approval, 2021- 2031F |
6.1.5 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Drug Monitoring, 2021- 2031F |
6.1.6 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Aggregating and Synthesizing Information, 2021- 2031F |
6.1.7 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Formation and Qualification of Hypotheses, 2021- 2031F |
6.1.8 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By De Novo Drug Design, 2021- 2031F |
6.1.9 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Taiwan Artificial Intelligence (AI) in Drug Discovery Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Machine Learning, 2021- 2031F |
6.2.3 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Deep Learning, 2021- 2031F |
6.2.4 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Natural Language Processing, 2021- 2031F |
6.2.5 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Taiwan Artificial Intelligence (AI) in Drug Discovery Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Small Molecule, 2021- 2031F |
6.3.3 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Large Molecule, 2021- 2031F |
6.4 Taiwan Artificial Intelligence (AI) in Drug Discovery Market, By Offering |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Software, 2021- 2031F |
6.4.3 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Services, 2021- 2031F |
6.5 Taiwan Artificial Intelligence (AI) in Drug Discovery Market, By Indication |
6.5.1 Overview and Analysis |
6.5.2 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Immuno-Oncology, 2021- 2031F |
6.5.3 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.5.4 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.5.5 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Metabolic Diseases, 2021- 2031F |
6.5.6 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Taiwan Artificial Intelligence (AI) in Drug Discovery Market, By End Use |
6.6.1 Overview and Analysis |
6.6.2 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Contract Research Organizations (CROs), 2021- 2031F |
6.6.3 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.6.4 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Research Centers and Academic Institutes, 2021- 2031F |
6.6.5 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Import-Export Trade Statistics |
7.1 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Export to Major Countries |
7.2 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Imports from Major Countries |
8 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Key Performance Indicators |
8.1 Percentage increase in the number of successful drug candidates discovered using AI |
8.2 Reduction in time taken for drug discovery process with the implementation of AI |
8.3 Increase in the number of collaborations between AI technology providers and pharmaceutical companies |
9 Taiwan Artificial Intelligence (AI) in Drug Discovery Market - Opportunity Assessment |
9.1 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Offering, 2021 & 2031F |
9.5 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.6 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Taiwan Artificial Intelligence (AI) in Drug Discovery Market - Competitive Landscape |
10.1 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Artificial Intelligence (AI) in Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here